Mesoblast Ltd. (MESO)
Mesoblast Market Cap: 2.426B for Dec. 29, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Telix Pharmaceuticals Ltd. | 2.624B |
| Alterity Therapeutics Ltd. | 54.74M |
| Kazia Therapeutics Ltd. | 10.32M |
| Immutep Ltd. | 438.13M |
| Propanc Biopharma, Inc. | 7.829M |
Market Cap Related Metrics
| PS Ratio | 133.06 |
| Price to Book Value | 4.834 |
| Price | 18.96 |
| Earnings Yield | -4.46% |